Bioventus Inc.BVSNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +13.45% | -4.31% | -2.35% | -0.23% | +2.77% |
| Gross Profit Growth | +18.95% | -6.02% | -1.49% | -0.77% | +1.75% |
| EBITDA Growth | +50.88% | -4.16% | +0.00% | +31.08% | +73.32% |
| Operating Income Growth | +585.67% | -1.20% | +0.00% | +197.10% | +171.92% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +3.87% | +4.15% | +3.81% | +2.55% | +1.79% |
| Weighted Average Shares Diluted Growth | +3.87% | +4.15% | +6.99% | +5.48% | +5.29% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +86.25% | +0.00% | +71.07% | +191.76% | +96.50% |
| Free Cash Flow Growth | +87.39% | +0.00% | +67.42% | +188.97% | +99.42% |
| Receivables Growth | +3.75% | -5.94% | -3.60% | +6.95% | +0.71% |
| Inventory Growth | +1.25% | -3.05% | +10.11% | +6.93% | -11.07% |
| Asset Growth | -10.23% | -12.95% | -10.78% | -8.82% | -6.10% |
| Book Value per Share Growth | -17.95% | -16.95% | +2.90% | +8.89% | +22.26% |
| Debt Growth | -15.00% | -11.58% | -10.97% | -15.90% | -7.23% |
| R&D Expense Growth | -0.49% | +14.62% | -24.66% | -23.24% | -7.36% |
| SG&A Expenses Growth | +10.54% | -6.69% | -18.16% | -4.05% | -4.45% |